ABUS vs STE
Arbutus Biopharma Corp (ABUS) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the ABUS and STE stock pages for the full models.
Not investment advice.